CDISC Selects Nextrials as a Registered Solutions Provider

CDISC Selects Nextrials as a Registered Solutions Provider
CDISC Singles Out Nextrials as the Only Company Offering an Electronic Data Capture Solution and Services Supporting Its Healthcare Link Initiative

SAN RAMON, Calif.--(BUSINESS WIRE)--Nextrials, Inc., a leader in clinical research software and services, has been approved by the Clinical Data Interchange Standards Consortium (CDISC) as one of 15 registered solutions providers, and is the only company offering an electronic data capture (EDC) product supporting the CDISC Healthcare Link Initiative. Begun in 2005, the CDISC Healthcare Link Initiative focuses on the interoperability of electronic health records (EHR) platforms with EDC technology for clinical trials.

"There are benefits to using an integrated EDC/EHR platform in the healthcare industry, and Nextrials should be applauded for its efforts in this arena"
.Nextrials' award-winning PrismTM, an EDC and clinical trial management platform, fully supports CDISC standards and has successfully demonstrated its interoperability with EHR through industry showcases at the Annual Healthcare Information and Management Systems Society (HIMSS) Conference and Exhibition, the Annual IHE North America Connectathon, the Society for Clinical Data Management (SCDM) Annual Conference and the Annual Meeting of the Drug Information Association. It is also the only platform successfully used in a multi-site study where real-time, live patient data was collected and shared by what had previously been two disparate data management platforms.

"There are benefits to using an integrated EDC/EHR platform in the healthcare industry, and Nextrials should be applauded for its efforts in this arena," commented Rebecca Kush, CDISC president and CEO. "By using a standards-based process, workflow for clinical research can be integrated into the workflow for clinical care. This streamlines the process for sharing clinical care information for multiple uses including research and public health. It promotes a reduction in time for data entry and increased data accuracy by eliminating transcription -- and, in turn, this would be expected to create a more efficient medical research environment."

Nextrials' award-winning Prism melds sophisticated clinical trial management functionality with EDC in a single, integrated package. By receiving a constant flow of data, Prism enables sponsors and sites to fully utilize real-time integration of disparate information and data sources, such as a hospital's EHR or patient records, to better provide a continuum of care for patients enrolled in clinical trials.

About Nextrials, Inc.

Founded by pharmaceutical researchers in 1999, Nextrials offers today's most novel products and services for speeding the delivery of life-saving drugs and medical devices to market. PrismTM, its award-winning Electronic Data Capture (EDC) solution, has been used at over 1,200 research sites to streamline the initiation and management of clinical trials. The company is headquartered in the San Francisco Bay area. For more information, visit www.nextrials.com or call 925-355-3000. A podcast by co-founder and CEO James Rogers on the incorporation of electronic health records into the clinical trial process is also available at http://pharmavoice.com/podcasts.


Contacts
VOXUS, Inc.
Rachel V. Berry, 253-853-5151, ext. 223
[email protected]

Suggested Articles

Insitro picked up $143 million to build out its technology, pursue new targets and advance treatments for genetically defined patient groups.

Generation Bio filed for a $215 million IPO to advance a pair of gene therapies for liver disease and push one of them into the clinic.

The IPO will push Avidity's lead muscle disorder program through IND-enabling studies and into the clinic in 2021.